Semin Respir Crit Care Med 2022; 43(01): 060-074
DOI: 10.1055/s-0041-1740982
Review Article

Severe Infections Due to Respiratory Viruses

Catia Cillóniz
1   Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona—Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB), Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain
,
Juan M. Pericàs
2   Department of Infectious Diseases, Hospital Clinic of Barcelona, Barcelona, Spain
3   Internal Medicine Department, Vall d'Hebron Institute for Research, Barcelona, Spain
,
Jorge R. Rojas
4   Department of Pneumology, Hospital Regional Docente Clínico Quirúrgico Daniel Alcides Carrión, Huancayo, Perú
,
Antoni Torres
1   Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona—Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB), Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain
› Author Affiliations
Funding This study was supported by CIBER de Enfermedades Respiratorias (CIBERES CB06/06/0028), and by 2009 Support to Research Groups of Catalonia 911; IDIBAPS. Dr Cillóniz is the recipient of the SEPAR fellowship 2018, and a grant from the Fondo de Investigación Sanitaria (PI19/00207).

Abstract

Severe viral infections may result in severe illnesses capable of causing acute respiratory failure that could progress rapidly to acute respiratory distress syndrome (ARDS), related to worse outcomes, especially in individuals with a higher risk of infection, including the elderly and those with comorbidities such as asthma, diabetes mellitus and chronic respiratory or cardiovascular disease. In addition, in cases of severe viral pneumonia, co-infection with bacteria such as Streptococcus pneumoniae and Staphylococcus aureus is related to worse outcomes. Respiratory viruses like influenza, rhinovirus, parainfluenza, adenovirus, metapneumovirus, respiratory syncytial virus, and coronavirus have increasingly been detected. This trend has become more prevalent, especially in critically ill patients, due to the availability and implementation of molecular assays in clinical practice. Respiratory viruses have been diagnosed as a frequent cause of severe pneumonia, including cases of community-acquired pneumonia, hospital-acquired pneumonia, and ventilator-associated pneumonia. In this review, we will discuss the epidemiology, diagnosis, clinical characteristics, management, and prognosis of patients with severe infections due to respiratory viruses, with a focus on influenza viruses, non-influenza viruses, and coronaviruses.



Publication History

Article published online:
16 February 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 World Health Organization. Research needs for the Battle against Respiratory Viruses (BRaVe). Published online 2013. Accessed September 1, 2021. Available at https://www.who.int/influenza/patient_care/clinical/BRaVe_Research_Agenda_2013.pdf?ua=1
  • 2 Bianchini S, Silvestri E, Argentiero A, Fainardi V, Pisi G, Esposito S. Role of respiratory syncytial virus in pediatric pneumonia. Microorganisms 2020; 8 (12) E2048
  • 3 Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet 2019; 394 (10200): 757-779
  • 4 Thorburn K, Eisenhut M, Riordan A. Mortality and morbidity of nosocomial respiratory syncytial virus (RSV) infection in ventilated children–a ten year perspective. Minerva Anestesiol 2012; 78 (07) 782
  • 5 Hei H, Bezpalko O, Smathers SA, Coffin SE, Sammons JS. Development of a novel prevention bundle for pediatric healthcare-associated viral infections. Infect Control Hosp Epidemiol 2018; 39 (09) 1086-1092
  • 6 Vanhems P, Bénet T, Munier-Marion E. Nosocomial influenza: encouraging insights and future challenges. Curr Opin Infect Dis 2016; 29 (04) 366-372
  • 7 Finelli L, Gupta V, Petigara T, Yu K, Bauer KA, Puzniak LA. Mortality among US patients hospitalized with SARS-CoV-2 infection in 2020. JAMA Netw Open 2021; 4 (04) e216556
  • 8 Clementi N, Ghosh S, De Santis M. et al. Viral respiratory pathogens and lung injury. Clin Microbiol Rev 2021; 34 (03) e00103-20
  • 9 Torres A, Cilloniz C, Niederman MS. et al. Pneumonia. Nat Rev Dis Primers 2021; 7 (01) 25
  • 10 Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology 2018; 23 (02) 130-137
  • 11 Voiriot G, Visseaux B, Cohen J. et al. Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia. Crit Care 2016; 20 (01) 375
  • 12 Cillóniz C, Ewig S, Ferrer M. et al. Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis. Crit Care 2011; 15 (05) R209
  • 13 Cillóniz C, Ewig S, Menéndez R. et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect 2012; 65 (03) 223-230
  • 14 Álvarez-Lerma F, Marín-Corral J, Vila C. et al; H1N1 GETGAG/SEMICYUC Study Group. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome. Crit Care 2016; 20 (01) 337
  • 15 Lee N, Walsh EE, Sander I. et al. Delayed diagnosis of respiratory syncytial virus infections in hospitalized adults: individual patient data, record review analysis and physician survey in the United States. J Infect Dis 2019; 220 (06) 969-979
  • 16 Metlay JP, Waterer GW, Long AC. et al. Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019; 200 (07) e45-e67
  • 17 GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396 (10258): 1204-1222
  • 18 Jain S, Self WH, Wunderink RG. et al; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. Adults. N Engl J Med 2015; 373 (05) 415-427
  • 19 Li Y, Reeves RM, Wang X. et al; RSV Global Epidemiology Network, RESCEU investigators. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health 2019; 7 (08) e1031-e1045
  • 20 Kodama F, Nace DA, Jump RLP. Respiratory syncytial virus and other noninfluenza respiratory viruses in older adults. Infect Dis Clin North Am 2017; 31 (04) 767-790
  • 21 Burk M, El-Kersh K, Saad M, Wiemken T, Ramirez J, Cavallazzi R. Viral infection in community-acquired pneumonia: a systematic review and meta-analysis. Eur Respir Rev 2016; 25 (140) 178-188
  • 22 Piralla A, Mariani B, Rovida F, Baldanti F. Frequency of respiratory viruses among patients admitted to 26 intensive care units in seven consecutive winter-spring seasons (2009-2016) in Northern Italy. J Clin Virol 2017; 92: 48-51
  • 23 Alimi Y, Lim WS, Lansbury L, Leonardi-Bee J, Nguyen-Van-Tam JS. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol 2017; 95: 26-35
  • 24 Zhou F, Wang Y, Liu Y. et al; CAP-China Network. Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network. Eur Respir J 2019; 54 (02) 1802406
  • 25 Cillóniz C, Dominedò C, Magdaleno D, Ferrer M, Gabarrús A, Torres A. Pure viral sepsis secondary to community-acquired pneumonia in adults: risk and prognostic factors. J Infect Dis 2019; 220 (07) 1166-1171
  • 26 Wang X, Li Y, Deloria-Knoll M. et al; Respiratory Virus Global Epidemiology Network. Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob Health 2021; 9 (01) e33-e43
  • 27 Yang X, Yu Y, Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8 (05) 475-481
  • 28 Al-Tawfiq JA, Zumla A, Gautret P. et al. Surveillance for emerging respiratory viruses. Lancet Infect Dis 2014; 14 (10) 992-1000
  • 29 Di Pasquale MF, Sotgiu G, Gramegna A. et al; GLIMP Investigators. Prevalence and etiology of community-acquired pneumonia in Immunocompromised Patients. Clin Infect Dis 2019; 68 (09) 1482-1493
  • 30 Ramirez JA, Musher DM, Evans SE. et al. Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies. Chest 2020; 158 (05) 1896-1911
  • 31 Luyt C-E, Combes A, Deback C. et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 2007; 175 (09) 935-942
  • 32 Coisel Y, Bousbia S, Forel J-M. et al. Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia. PLoS One 2012; 7 (12) e51340
  • 33 Vergara A, Cilloniz C, Luque N. et al. Detection of human cytomegalovirus in bronchoalveolar lavage of intensive care unit patients. Eur Respir J 2018; 51 (02) 1701332
  • 34 Karhu J, Ala-Kokko TI, Vuorinen T, Ohtonen P, Syrjälä H. Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia. Clin Infect Dis 2014; 59 (01) 62-70
  • 35 Nguyen C, Kaku S, Tutera D, Kuschner WG, Barr J. Viral respiratory infections of adults in the intensive care unit. J Intensive Care Med 2016; 31 (07) 427-441
  • 36 Choi S-H, Hong S-B, Ko G-B. et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 2012; 186 (04) 325-332
  • 37 Hasvold J, Sjoding M, Pohl K, Cooke C, Hyzy RC. The role of human metapneumovirus in the critically ill adult patient. J Crit Care 2016; 31 (01) 233-237
  • 38 Garg S, Jain S, Dawood FS. et al. Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection-United States, 2005-2008. BMC Infect Dis 2015; 15: 369
  • 39 Hong H-L, Hong S-B, Ko G-B. et al. Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia. PLoS One 2014; 9 (04) e95865
  • 40 Loubet P, Voiriot G, Houhou-Fidouh N. et al. Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: a single-center retrospective study. J Clin Virol 2017; 91: 52-57
  • 41 van Someren Gréve F, Juffermans NP, Bos LDJ. et al. Respiratory viruses in invasively ventilated critically ill patients—a prospective multicenter observational study. Crit Care Med 2018; 46 (01) 29-36
  • 42 Daubin C, Parienti J-J, Vincent S. et al. Epidemiology and clinical outcome of virus-positive respiratory samples in ventilated patients: a prospective cohort study. Crit Care 2006; 10 (05) R142
  • 43 Chow EJ, Mermel LA. Hospital-acquired respiratory viral infections: incidence, morbidity, and mortality in pediatric and adult patients. Open Forum Infect Dis 2017; 4 (01) ofx006
  • 44 Micek ST, Chew B, Hampton N, Kollef MH. A case-control study assessing the impact of nonventilated hospital-acquired pneumonia on patient outcomes. Chest 2016; 150 (05) 1008-1014
  • 45 Shorr AF, Fisher K, Micek ST, Kollef MH. The burden of viruses in pneumonia associated with acute respiratory failure: an underappreciated issue. Chest 2018; 154 (01) 84-90
  • 46 Zhang H, Han Y, Jin Z. et al. Detection of viruses by multiplex real-time polymerase chain reaction in bronchoalveolar lavage fluid of patients with nonresponding community-acquired pneumonia. Can Respir J 2020; 2020: 8715756
  • 47 Wabe N, Li L, Lindeman R. et al. The impact of rapid molecular diagnostic testing for respiratory viruses on outcomes for emergency department patients. Med J Aust 2019; 210 (07) 316-320
  • 48 Rogers BB, Shankar P, Jerris RC. et al. Impact of a rapid respiratory panel test on patient outcomes. Arch Pathol Lab Med 2015; 139 (05) 636-641
  • 49 Torres A, Lee N, Cilloniz C, Vila J, Van der Eerden M. Laboratory diagnosis of pneumonia in the molecular age. Eur Respir J 2016; 48 (06) 1764-1778
  • 50 Huang H-S, Tsai C-L, Chang J, Hsu T-C, Lin S, Lee C-C. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis. Clin Microbiol Infect 2018; 24 (10) 1055-1063
  • 51 Luyt C-E. Virus diseases in ICU patients: a long time underestimated; but be aware of overestimation. Intensive Care Med 2006; 32 (07) 968-970
  • 52 Brendish NJ, Malachira AK, Armstrong L. et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med 2017; 5 (05) 401-411
  • 53 Robert S, Lhommet C, Le Brun C. et al. Diagnostic performance of multiplex PCR on pulmonary samples versus nasopharyngeal aspirates in community-acquired severe lower respiratory tract infections. J Clin Virol 2018; 108: 1-5
  • 54 Tsao Y-T, Tsai Y-H, Liao W-T, Shen C-J, Shen C-F, Cheng C-M. Differential markers of bacterial and viral infections in children for point-of-care testing. Trends Mol Med 2020; 26 (12) 1118-1132
  • 55 Thomas J, Pociute A, Kevalas R, Malinauskas M, Jankauskaite L. Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review. Ital J Pediatr 2020; 46 (01) 4
  • 56 van Asten L, Luna Pinzon A, van de Kassteele J. et al. The association between influenza infections in primary care and intensive care admissions for severe acute respiratory infection (SARI): a modelling approach. Influenza Other Respir Viruses 2020; 14 (05) 575-586
  • 57 CDC. 2009 H1N1 Pandemic (H1N1pdm09 virus). Accessed September 5, 2021. Available at https://www.cdc.gov/flu/pandemic-resources/2009-h1n1-pandemic.html
  • 58 GBD 2017 Influenza Collaborators. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2019; 7 (01) 69-89
  • 59 World Health Organization. Universal Health Coverage Global Monitoring Report. 2019
  • 60 Iuliano AD, Roguski KM, Chang HH. et al; Global Seasonal Influenza-associated Mortality Collaborator Network. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018; 391 (10127): 1285-1300
  • 61 CDC. 2019–2020 U.S. Flu Season: Preliminary In-Season Burden Estimates. Published online 2021. Accessed September 5, 2021. Available at https://www.cdc.gov/flu/about/burden/preliminary-in-season-estimates.htm
  • 62 Short KR, Kroeze EJBV, Fouchier RAM, Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis 2014; 14 (01) 57-69
  • 63 Baral N, Adhikari P, Adhikari G, Karki S. Influenza myocarditis: a literature review. Cureus 2020; 12 (12) e12007
  • 64 Sarda C, Palma P, Rello J. Severe influenza: overview in critically ill patients. Curr Opin Crit Care 2019; 25 (05) 449-457
  • 65 Cillóniz C, Civljak R, Nicolini A, Torres A. Polymicrobial community-acquired pneumonia: an emerging entity. Respirology 2016; 21 (01) 65-75
  • 66 Klein EY, Monteforte B, Gupta A. et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses 2016; 10 (05) 394-403
  • 67 Uyeki TM, Bernstein HH, Bradley JS. et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis 2019; 68 (06) e1-e47
  • 68 Herold S, Becker C, Ridge KM, Budinger GRS. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J 2015; 45 (05) 1463-1478
  • 69 Rodríguez A, Díaz E, Martín-Loeches I. et al; H1N1 SEMICYUC Working Group. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother 2011; 66 (05) 1140-1149
  • 70 Casalino E, Antoniol S, Fidouh N. et al. Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: a 3-year prospective observational study during seasonal epidemic periods. PLoS One 2017; 12 (08) e0182191
  • 71 Maruyama T, Fujisawa T, Suga S. et al. Outcomes and prognostic features of patients with influenza requiring hospitalization and receiving early antiviral therapy: a prospective multicenter cohort study. Chest 2016; 149 (02) 526-534
  • 72 Abaziou T, Delmas C, Vardon Bounes F. et al. Outcome of critically ill patients with influenza infection: a retrospective study. Infect Dis (Auckl) 2020; 13: 1178633720904081
  • 73 Miyashita K, Nakatani E, Hozumi H, Sato Y, Miyachi Y, Suda T. Risk factors for pneumonia and death in adult patients with seasonal influenza and establishment of prediction scores: a population-based study. Open Forum Infect Dis 2021; 8 (03) b068
  • 74 Bonmarin I, Belchior E, Bergounioux J. et al. Intensive care unit surveillance of influenza infection in France: the 2009/10 pandemic and the three subsequent seasons. Euro Surveill 2015;20(46):
  • 75 Li H, Weng H, Lan C. et al. Comparison of patients with avian influenza A (H7N9) and influenza A (H1N1) complicated by acute respiratory distress syndrome. Medicine (Baltimore) 2018; 97 (12) e0194
  • 76 Pronier C, Gacouin A, Lagathu G, Le Tulzo Y, Tadié J-M, Thibault V. Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms. J Clin Virol 2021; 136: 104761
  • 77 Coste A, Frérou A, Raute A. et al. The extent of aspergillosis in critically ill patients with severe influenza pneumonia: a multicenter cohort study. Crit Care Med 2021; 49 (06) 934-942
  • 78 Schauwvlieghe AFAD, Rijnders BJA, Philips N. et al; Dutch-Belgian Mycosis study group. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med 2018; 6 (10) 782-792
  • 79 Grupo de Trabajo Gripe A Grave (GETGAG) de la Sociedad Española de Medicina Intensiva Crítica y Unidades Coronarias. (SEMICYUC). Spanish Influenza Score (SIS): usefulness of machine learning in the development of an early mortality prediction score in severe influenza. Med Intensiva 2021; Mar; 45 (02) 69-79
  • 80 Chen L, Han X-D, Li Y-L, Zhang C-X, Xing X-Q. Comparison of the clinical characteristics and severity of influenza and non-influenza respiratory virus-related pneumonia in China: a multicenter, real-world study. Infect Drug Resist 2020; 13: 3513-3523
  • 81 Choi S-H, Huh JW, Hong S-B. et al. Clinical characteristics and outcomes of severe rhinovirus-associated pneumonia identified by bronchoscopic bronchoalveolar lavage in adults: comparison with severe influenza virus-associated pneumonia. J Clin Virol 2015; 62: 41-47
  • 82 Azoulay E, Russell L, Van de Louw A. et al; Nine-i Investigators. Diagnosis of severe respiratory infections in immunocompromised patients. Intensive Care Med 2020; 46 (02) 298-314
  • 83 Collins JP, Campbell AP, Openo K. et al. Outcomes of immunocompromised adults hospitalized with laboratory-confirmed influenza in the United States, 2011-2015. Clin Infect Dis 2020; 70 (10) 2121-2130
  • 84 Lynch III JP, Kajon AE. Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention. Semin Respir Crit Care Med 2016; 37 (04) 586-602
  • 85 Branche AR, Falsey AR. Parainfluenza virus infection. Semin Respir Crit Care Med 2016; 37 (04) 538-554
  • 86 Fragkou PC, Moschopoulos CD, Karofylakis E, Kelesidis T, Tsiodras S. Update in viral infections in the intensive care unit. Front Med (Lausanne) 2021; 8: 575580
  • 87 Elabbadi A, Pichon J, Visseaux B. et al. Respiratory virus-associated infections in HIV-infected adults admitted to the intensive care unit for acute respiratory failure: a 6-year bicenter retrospective study (HIV-VIR study). Ann Intensive Care 2020; 10: 123
  • 88 Ison MG. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43 (03) 331-339
  • 89 Dudding BA, Wagner SC, Zeller JA, Gmelich JT, French GR, Top Jr FH. Fatal pneumonia associated with adenovirus type 7 in three military trainees. N Engl J Med 1972; 286 (24) 1289-1292
  • 90 Zhao J, Yap A, Wu E, Low CY, Yap J. Severe community acquired adenovirus pneumonia in an immunocompetent host successfully treated with IV Cidofovir. Respir Med Case Rep 2020; 30: 101037
  • 91 Barker JH, Luby JP, Sean Dalley A, Bartek WM, Burns DK, Erdman DD. Fatal type 3 adenoviral pneumonia in immunocompetent adult identical twins. Clin Infect Dis 2003; 37 (10) e142-e146
  • 92 Le TK, Brown BK, Namtu KC, Berman DM, Kiskaddon AL. Use of cidofovir with extracorporeal membrane oxygenation to treat adenovirus-associated acute respiratory distress syndrome in paediatric patients- a case series. J Clin Pharm Ther 2020; 45 (06) 1505-1510
  • 93 Ko J-H, Lim JU, Choi JY. et al. Early cidofovir administration might be associated with a lower probability of respiratory failure in treating human adenovirus pneumonia: a retrospective cohort study. Clin Microbiol Infect 2020; 26 (05) 646.e9-646.e14
  • 94 Moon SM, Choe J, Na SJ, Chung CR, Suh GY, Jeon K. Comparative study on the effect of cidofovir treatment for severe adenovirus pneumonia. J Intens Care Med 2020; 885066620960687
  • 95 De Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 14 (08) 523-534
  • 96 Coronavirus Resource Center. Johns Hopkins Coronavirus Resource Center. Accessed April 12, 2021 at: https://coronavirus.jhu.edu/
  • 97 Xie M, Chen Q. Insight into 2019 novel coronavirus—an updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis 2020; 94: 119-124
  • 98 Carrillo-Larco RM, Altez-Fernandez C. Anosmia and dysgeusia in COVID-19: a systematic review. Wellcome Open Res 2020; 5: 94
  • 99 Carignan A, Valiquette L, Grenier C. et al. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study. CMAJ 2020; 192 (26) E702-E707
  • 100 Dev N, Sankar J, Gupta N. et al. COVID-19 with and without anosmia or dysgeusia: a case-control study. J Med Virol 2021; 93 (04) 2499-2504
  • 101 Eshraghi AA, Mirsaeidi M, Davies C, Telischi FF, Chaudhari N, Mittal R. Potential mechanisms for COVID-19 induced anosmia and dysgeusia. Front Physiol 2020; 11: 1039
  • 102 Wong HYF, Lam HYS, Fong AH-T. et al. Frequency and distribution of chest radiographic findings in patients positive for COVID-19. Radiology 2020; 296 (02) E72-E78
  • 103 Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol 2020; 30 (08) 4381-4389
  • 104 Verma HK. Radiological and clinical spectrum of COVID-19: a major concern for public health. World J Radiol 2021; 13 (03) 53-63
  • 105 Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021; 19 (03) 141-154
  • 106 Zhang JJY, Lee KS, Ang LW, Leo YS, Young BE. Risk factors for severe disease and efficacy of treatment in patients infected with COVID-19: a systematic review, meta-analysis, and meta-regression analysis. Clin Infect Dis 2020; 71 (16) 2199-2206
  • 107 Petrilli CM, Jones SA, Yang J. et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020; 369: m1966
  • 108 Berenguer J, Ryan P, Rodríguez-Baño J. et al; COVID-19@Spain Study Group, Fundación SEIMC-GESIDA, Hospital General Universitario Gregorio Marañón, Hospital Universitario La Paz, Hospital Infanta Leonor, Complejo Hospitalario Virgen de la Salud, Hospital Universitario Rafael Méndez, Hospital Universitario de Cruces, Hospital de Melilla, Hospital San Eloy de Barakaldo, Hospital Universitario Central de Asturias, Hospital General Universitario de Alicante, Hospital Virgen de la Victoria, Hospital Universitario Puerto Real, EOXI Pontevedra e Salnés, Hospital de Figueres, Hospital Sant Jaume de Calella, Hospital del Mar, Hospital Virgen de la Arrixaca, Hospital de Can Misses, Hospital de Sagunto, Hospital Clínico San Cecilio, Hospital Universitario Príncipe de Asturias, Parc Sanitari Sant Joan de Déu, Hospital Nuestra Señora de Gracia, HC Marbella Internacional Hospital, Hospital La Princesa, Hospital Josep Trueta, Hospital Dos de Maig, Hospital Arnau de Vilanova-Lliria, Hospital General Universitario de Elche, Hospital Clínico Universitario de Valencia, Complejo Asistencial de Ávila, Hospital Comarcal de Alcañiz, Hospital Universitario Marqués de Valdecilla, Hospital Quiron-Salud de Torrevieja, Hospital Universitario Miguel Servet, SCIAS, Hospital de Barcelona, Fundación Hospital Universitario Alcorcón, Hospital Álvaro Cunqueiro, Complejo Asistencial Universitario de Salamanca, Hospital Universitario Severo Ochoa, Hospital CIMA-Sanitas, Hospital HLA Inmaculada, Hospital Universitario Rio Hortega, Hospital de Guadalajara, Hospital Universitario Infanta Sofía, Hospital Comarcal de Blanes, Hospital Universitari de Tarragona Joan XXIII, Hospital Universitario Basurto, Hospital Universitario de Canarias, Hospital Universitario de Gran Canaria Dr Negrín, Hospital Son Espases, Hospital Universitario de Móstoles, Complejo Hospitalario Universitario A Coruña, Hospital Costa del Sol, Hospital Clínico Universitario Lozano Blesa, Hospital Mutua de Terrassa, Hospital de la Plana, Hospital Virgen de la Concha–Complejo Asistencial de Zamora, Complejo Hospitalario Universitario Insular Materno-Infantil, Hospital de la Marina Baixa, Hospital Universitario Virgen Macarena, Hospital Universitari de Bellvitge, Hospital Universitario y Politécnico la Fe, Hospital Universitario del Vinalopó, Hospital de Sabadell (Parc Tauli), Hospital Clinic de Barcelona, Hospital Universitario de la Ribera, Fundación Jiménez Díaz, Hospital Clínico Universitario de Valladolid, Hospital Clínico San Carlos, Hospital Santa Creu i Sant Pau, Clínica Universitaria de Navarra–Campus Madrid, Hospital Son Llatzer, Hospital General de la Defensa Gómez Ulla, Hospital Universitario de Álava, Hospital Santos Reyes, Hospital Dr José Molina Orosa, Hospital Vall d'Hebrón, Hospital Universitario Rey Juan Carlos, Complejo Hospitalario Universitario Santa Lucía, Hospital Santa Bárbara, Complejo Hospitalario Universitario de Ferrol, Hospital de l'Esperit Sant, Hospital Universitario los Arcos del Mar Menor, Hospital HLA Universitario Moncloa, Hospital Virgen del Puerto, Hospital Marina Salud de Dénia, Hospital Universitario de Jerez, Hospital Reina Sofía de Tudela, Hospital Clínico Universitario de Santiago de Compostela, Hospital Universitario del Henares, Hospital Universitario Lucus Augusti, Hospital de Donostia, Hospital de Urduliz Alfredo Espinosa, Hospital de Mendaro, Hospital Juan Ramón Jiménez, Hospital de Tortosa Virgen de la Cinta, Hospital Riotinto, Hospital Vega Baja, Hospital Puerta de Hierro, Hospital Universitario de Getafe, Hospital General de la Palma, Hospital El Bierzo, Fundación Hospital de Calahorra, Hospital Alto Deba, Hospital Universitario San Juan de Alicante, Hospital de Guadarrama, Hospital Universitario de Jaén, Hospital de Mataró, Hospital de Palamós, Hospital Universitario de Valme, Clínica Universitaria de Navarra–Campus Navarra, Hospital Clínica Benidorm, Hospital Doce de Octubre, Hospital Universitario Virgen del Rocío, Hospital Universitario Ramón y Cajal, Hospital Universitario San Pedro, Hospital Quirón A Coruña, HM Sanchinarro, Hospital Francesc de Borja, Complejo Hospitalario Universitario Nuestra Señora de La Candelaria, Hospital Universitario HM Montepríncipe, Hospital Universitario HM Puerta del Sur, Hospital Universitario HM Torrelodones, Hospital Universitario HM Madrid, Hospital Don Benito-Villanueva de la Serena, Hospital de Viladecans, Centro Nacional de Epidemiología. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect 2020; 26 (11) 1525-1536
  • 109 Xu J, Yang X, Yang L. et al. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care 2020; 24 (01) 394
  • 110 Ferrando C, Mellado-Artigas R, Gea A. et al; de la Red de UCI Española para COVID-19. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: a prospective, cohort, multicentre study. Rev Esp Anestesiol Reanim (Engl Ed) 2020; 67 (08) 425-437
  • 111 Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis. J Med Virol 2020; 92 (06) 612-617
  • 112 Banfi P, Garuti G, Diaz de TeranT, Ruiz J, Ferraioli G, Russo G. et al. Differences between sexes concerning COVID-19-related pneumonia. Panminerva Med 2021; DOI: 10.23736/S0031-0808.21.04165-3.
  • 113 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA 2020; 323 (13) 1239-1242
  • 114 Denison MR. Severe acute respiratory syndrome coronavirus pathogenesis, disease and vaccines: an update. Pediatr Infect Dis J 2004; 23 (Suppl. 11) S207-S214
  • 115 Al-Tawfiq JA, Kattan RF, Memish ZA. Middle East respiratory syndrome coronavirus disease is rare in children: an update from Saudi Arabia. World J Clin Pediatr 2016; 5 (04) 391-396
  • 116 Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis 2020; 20 (06) 689-696
  • 117 Garazzino S, Lo Vecchio A, Pierantoni L. et al; Italian SITIP-SIP Pediatric Infection Study Group. Epidemiology, clinical features and prognostic factors of pediatric SARS-CoV-2 infection: results from an Italian Multicenter Study. Front Pediatr 2021; 9: 649358
  • 118 Panigrahy N, Policarpio J, Ramanathan R. Multisystem inflammatory syndrome in children and SARS-CoV-2: a scoping review. J Pediatr Rehabil Med 2020; 13 (03) 301-316
  • 119 García-Salido A, de Carlos Vicente JC, Belda Hofheinz S. et al; Spanish Pediatric Intensive Care Society working group on SARS-CoV-2 infection. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain. Crit Care 2020; 24 (01) 666
  • 120 Pereira MFB, Litvinov N, Farhat SCL. et al; Pediatric COVID HC-FMUSP Study Group. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome. Clinics (São Paulo) 2020; 75: e2209
  • 121 Vogel TP, Top KA, Karatzios C. et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2021; 39 (22) 3037-3049
  • 122 Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY) 2020; 12 (07) 6049-6057
  • 123 Ou M, Zhu J, Ji P. et al. Risk factors of severe cases with COVID-19: a meta-analysis. Epidemiol Infect 2020; 148: e175
  • 124 Sur M, Lopez MJ, Baker MB. Oseltamivir. In: StatPearls. StatPearls Publishing; 2021. . Accessed June 21, 2021 at: http://www.ncbi.nlm.nih.gov/books/NBK539909/
  • 125 Muthuri SG, Venkatesan S, Myles PR. et al; PRIDE Consortium Investigators. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2014; 2 (05) 395-404
  • 126 Moreno G, Rodríguez A, Sole-Violán J. et al. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia. ERJ Open Res 2021; 7 (01) 00888-2020
  • 127 Lytras T, Mouratidou E, Andreopoulou A, Bonovas S, Tsiodras S. Effect of early oseltamivir treatment on mortality in critically ill patients with different types of influenza: a multiseason cohort study. Clin Infect Dis 2019; 69 (11) 1896-1902
  • 128 Behillil S, May F, Fourati S. et al. Oseltamivir resistance in severe influenza A(H1N1)pdm09 pneumonia and acute respiratory distress syndrome: a French Multicenter Observational Cohort Study. Clin Infect Dis 2020; 71 (04) 1089-1091
  • 129 Chen H-D, Wang X, Yu S-L, Ding Y-H, Wang M-L, Wang J-N. Clinical effectiveness of intravenous peramivir compared with oseltamivir in patients with severe influenza a with primary viral pneumonia: a randomized controlled study. Open Forum Infect Dis 2020; 8 (01) a562
  • 130 Dandachi D, Rodriguez-Barradas MC. Viral pneumonia: etiologies and treatment. J Investig Med 2018; 66 (06) 957-965
  • 131 Beigel JH, Tomashek KM, Dodd LE. et al; ACTT-1 Study Group Members. Remdesivir for the treatment of COVID-19—final report. N Engl J Med 2020; 383 (19) 1813-1826
  • 132 Pan H, Peto R, Henao-Restrepo AM. et al; WHO Solidarity Trial Consortium. Repurposed antiviral drugs for COVID-19—interim WHO solidarity trial results. N Engl J Med 2021; 384 (06) 497-511
  • 133 Tleyjeh IM, Kashour Z, Damlaj M. et al. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis. Clin Microbiol Infect 2021; 27 (02) 215-227
  • 134 Salama C, Han J, Yau L. et al. Tocilizumab in patients hospitalized with COVID-19 pneumonia. N Engl J Med 2021; 384 (01) 20-30
  • 135 Hermine O, Mariette X, Tharaux P-L, Resche-Rigon M, Porcher R, Ravaud P. CORIMUNO-19 Collaborative Group. Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern Med 2021; 181 (01) 32-40
  • 136 Rajasingham R, Bangdiwala AS, Nicol MR. et al. Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial. Clin Infect Dis 2021; Jun 1; 72 (11) e835-e843
  • 137 Boulware DR, Pullen MF, Bangdiwala AS. et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med 2020; 383 (06) 517-525
  • 138 RECOVERY Collaborative Group. Horby P, Lim WS. et al. Dexamethasone in hospitalized patients with COVID-19—preliminary report. N Engl J Med 2021; Feb 25; 384 (08) 693-704
  • 139 Tomazini BM, Maia IS, Cavalcanti AB. et al; Coalition COVID-19 Brazil III Investigators. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA 2020; 324 (13) 1307-1316
  • 140 Horby P, Lim WS, Emberson JR. et al; RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 2021; 384 (08) 693-704
  • 141 WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Sterne JAC, Murthy S. et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: meta-analysis A. JAMA 2020; 324 (13) 1330-1341
  • 142 Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol 2021; 21 (04) 245-256
  • 143 Martin-Loeches I, Torres A. Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?. Eur Respir Rev 2021; 30 (159) 200346
  • 144 Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev 2019; 2: CD010406
  • 145 Ni YN, Chen G, Sun J, Liang BM, Liang ZA. The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Crit Care 2019; 23 (01) 99
  • 146 Zhou Y, Fu X, Liu X. et al. Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis. Sci Rep 2020; 10 (01) 3044
  • 147 Moreno G, Rodríguez A, Reyes LF. et al; GETGAG Study Group. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Med 2018; 44 (09) 1470-1482
  • 148 Okuno D, Kido T, Muramatsu K. et al. Impact of corticosteroid administration within 7 days of the hospitalization for influenza pneumonia with respiratory failure: a propensity score analysis using a nationwide administrative database. J Clin Med 2021; 10 (03) 494
  • 149 Therapeutic Management. COVID-19 Treatment Guidelines. Accessed April 12, 2021 at: https://www.covid19treatmentguidelines.nih.gov/therapeutic-management/
  • 150 Therapeutics and COVID-19: living guideline. Available at: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-therapeutics-2021.1
  • 151 Pasin L, Navalesi P, Zangrillo A. et al. Corticosteroids for patients with coronavirus disease 2019 (COVID-19) with different disease severity: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 2021; 35 (02) 578-584
  • 152 Peek GJ, Mugford M, Tiruvoipati R. et al; CESAR trial collaboration. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374 (9698): 1351-1363
  • 153 Zangrillo A, Biondi-Zoccai G, Landoni G. et al. Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care 2013; 17 (01) R30
  • 154 Sukhal S, Sethi J, Ganesh M, Villablanca PA, Malhotra AK, Ramakrishna H. Extracorporeal membrane oxygenation in severe influenza infection with respiratory failure: a systematic review and meta-analysis. Ann Card Anaesth 2017; 20 (01) 14-21
  • 155 Steimer DA, Hernandez O, Mason DP, Schwartz GS. Timing of ECMO initiation impacts survival in influenza-associated ARDS. Thorac Cardiovasc Surg 2019; 67 (03) 212-215
  • 156 Choi WS, Kang C-I, Kim Y. et al; Korean Society of Infectious Diseases. Clinical presentation and outcomes of middle east respiratory syndrome in the Republic of Korea. Infect Chemother 2016; 48 (02) 118-126
  • 157 Rhee J-Y, Hong G, Ryu KM. Clinical implications of 5 cases of Middle East respiratory syndrome coronavirus infection in a South Korean outbreak. Jpn J Infect Dis 2016; 69 (05) 361-366
  • 158 Al-Dorzi HM, Aldawood AS, Khan R. et al. The critical care response to a hospital outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: an observational study. Ann Intensive Care 2016; 6 (01) 101
  • 159 Arabi YM, Al-Omari A, Mandourah Y. et al; Saudi Critical Care Trial Group. Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study. Crit Care Med 2017; 45 (10) 1683-1695
  • 160 Alshahrani MS, Sindi A, Alshamsi F. et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care 2018; 8 (01) 3
  • 161 Shalhoub S, Al-Hameed F, Mandourah Y. et al. Critically ill healthcare workers with the middle east respiratory syndrome (MERS): a multicenter study. PLoS One 2018; 13 (11) e0206831
  • 162 Barbaro RP, MacLaren G, Boonstra PS. et al; Extracorporeal Life Support Organization. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet 2020; 396 (10257): 1071-1078
  • 163 Extracorporeal Life Support Organization (ELSO). Accessed September 1, 2021. Available at https://www.elso.org/COVID19.aspx
  • 164 Diaz RA, Graf J, Zambrano JM. et al. ECMO for COVID-19-associated severe ARDS in Chile: a nationwide incidence and cohort study. Am J Respir Crit Care Med 2021; Jul 1; 204 (01) 34-43
  • 165 Schmidt M, Hajage D, Lebreton G. et al; Groupe de Recherche Clinique en REanimation et Soins intensifs du Patient en Insuffisance Respiratoire aiguE (GRC-RESPIRE) Sorbonne Université, Paris-Sorbonne ECMO-COVID investigators. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. Lancet Respir Med 2020; 8 (11) 1121-1131
  • 166 Badulak J, Antonini MV, Stead CM. et al. ECMO for COVID-19: updated 2021 guidelines from the extracorporeal life support organization (ELSO). ASAIO J 2021; 67 (05) 485-495